Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis.
[Symptoms and clinical manifestations in neuromyelitis optica].
Relationship between gait initiation and disability in individuals affected by multiple sclerosis.
Orthopaedic Management of Spasticity.
Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Oral corticosteroids for multiple sclerosis relapse.
Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains.
Human endogenous retrovirus-K contributes to motor neuron disease.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
The Nogo/ Nogo-66 receptor (NgR) signal is involved in neuroinflammation through the regulation of microglia inflammatory mediator expression.
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
Differential screening-selected gene aberrative in neuroblastoma (DAN) is increased in the CSF of patients with MS and may be induced by therapy with interferon-β.
Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.
The Relationships Between Apathy and Executive Dysfunction in Multiple Sclerosis.
Autoimmune priming tissue attack and chronic inflammation - The three stages of rheumatoid arthritis.
Pain and Cognition in Multiple Sclerosis.
Myelination, oligodendrocytes, and serious mental illness.
Tract-based spatial statistics of the olfactory brain in patients with multiple sclerosis.
Fish and egg specific immunoglobin e in multiple sclerosis patients.
Optic nerve head component responses of the multifocal electroretinogram in MS.
The coexistence of multiple sclerosis and hereditary spastic paraparesis in a patient.
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.
Pages
« first
‹ previous
…
564
565
566
567
568
569
570
571
572
…
next ›
last »